Two Drugs Helped One Woman Whose Breast Cancer Spread to the Brain
Original title: Favorable Response to Bevacizumab Plus Capecitabine in a HER2-negative Breast Cancer Patient with Recurrent Brain Metastases: A Case Report.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This is a report on one patient, not a real study, so it is not proven.
The short version
Doctors report that a drug pair helped one woman after her brain tumors came back.
What was studied. This is a report about one patient. She was a 41 year old woman with breast cancer that had spread to her brain. Her brain spots kept growing after surgery, radiation, and earlier chemotherapy. Her doctors then gave her two drugs together, capecitabine and bevacizumab.
What they found. Her symptoms got better after one round of treatment. Her doctors said the brain spots got smaller, but did not go away. She started the two drugs in February 2025. As of December 9, 2025, her cancer had not grown for 10 months. One time her blood counts dropped too low, and that was treated and controlled.
What this means, and what it doesn't
What it could mean: There are very few options for this kind of breast cancer once it reaches the brain. This report says one woman did well on these two drugs together. It may be worth asking your care team about, since both drugs are already used in cancer care.
What it doesn't mean: This is a report about one person, not a study of many people. One person doing well does not show the drugs will work for others. It does not tell us how safe or helpful this pair is in general. It is not a cure, and it is not proof. Bigger studies in people would be needed before this becomes normal care.
Source: PubMed, August 6, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.